Investors

Half year Median Technologies liquidity contract statement contracted with TP ICAP (Europe)

13 July 2021, Sophia Antipolis, France

Press release – For immediate release – 5:45 PM CEST

Half year Median Technologies liquidity contract statement contracted with TP ICAP (Europe)

 Under the liquidity contract entrusted by Median Technologies (FR0011049824 – ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account as of June 30, 2021:

  • 17,352 shares
  • €245,154.23 in cash

Transactions during the first half 2021:

BUY 131,632 shares 1,450,184.48 EUR 403 transactions
SELL 149,978 shares 1,618,612.23 EUR 465 transactions

 For information, as of December 31st, 2020, the following resources were listed in the liquidity contract:

  • 35,698 shares
  • €79,709.31 in cash

For information, as of May 4th, 2020, when the new liquidity contract was set up, the following resources were listed in the liquidity account:

  • 4,404 shares
  • €173,829.64 in cash

The daily transaction table is provided in the appendix to this press release.

TP ICAP (Europe) is authorized and regulated by the Autorité de Controle Prudentiel (ACPR) and the Autorité des Marchés Financiers (AMF).

About Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment strategies. Our unique solutions for medical image analysis and management in oncology trials and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median has received the “Innovative Company” label from BPI France, is eligible for the French SME equity savings plan scheme (PEA-PME), is listed on the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label.

Contacts

Median Technologies

Emmanuelle Leygues
Head of Corporate and Marketing Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Actifin  (Investors)

Ghislaine Gasparetto
+33 1 56 88 11 11
ggasparetto@actifin.fr

Alizé RP  (Press)

Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com